Part 2: Expense Measures (Continued)
Health and Ageing
Cancer Australia and the National Breast and Ovarian Cancer Centre — creating a single national cancer control agency
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Cancer Australia | - | - | - | - | - |
| National Breast and Ovarian Cancer Centre | - | - | - | - | - |
| Department of Health and Ageing | - | - | - | - | - |
| Total | - | - | - | - | - |
The Government will merge Cancer Australia and the National Breast and Ovarian Cancer Centre into a single national agency on 1 July 2011. The merger will provide a more sustainable financial and governance structure and improve coordination of the Government's cancer control, prevention, treatment and care programs.
The single agency will continue to provide national leadership in cancer control, with targeted research, education for cancer professionals, coordination of service development across Australia, and engagement with stakeholders and people affected by cancer.
This measure will be cost neutral. Provision for this funding has already been included in the forward estimates.
This measure was originally reported in the Economic Statement 2010.
COAG National food standards — improving consistency
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | - | - | - | - |
The Government will provide $4.3 million over four years to provide centralised and consistent advice on food standards within Australia and New Zealand.
This funding will enable Food Standards Australia New Zealand (FSANZ) to provide interpretive advice of the Australia New Zealand Food Standards Code in cases where a dispute arises between the food industry members and individual state and territory interpretations of the code. FSANZ has the primary responsibility for setting standards for the sale of food in Australia and New Zealand, however the interpretation of the code is the responsibility of individual states and territories. This measure will reduce the regulatory burden on the food industry by developing a more consistent interpretation of the Australia New Zealand Food Standards Code across all jurisdictions.
Reforming the regulation of the food industry has been supported by the Council of Australian Governments.
Funding for this measure was included as a 'decision taken but not yet announced' in the 2010‑11 Budget.
More information can be found in the outcomes of the Council of Australian Governments' Business Regulation and Competition Working Group meeting of 29 November 2008.
This measure was originally reported in the Pre-Election Economic and Fiscal Outlook 2010.
Emergency department medical workforce — additional resources
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | - | - | - | - |
The Government will provide $95.9 million over four years to deliver more and better qualified staff in emergency departments. This will be achieved by:
- training more emergency doctors;
- upskilling emergency nurses, care workers and international medical graduates;
- increasing emergency placements in universities; and
- providing educational and supervision support for more doctors to obtain alternative qualifications in emergency medicine.
This measure includes funding of $13.3 million in 2010‑11, $23.9 million in 2011‑12, $27.5 million in 2012‑13 and $31.1 million in 2013‑14, and was included as a 'decision taken but not yet announced' in the 2010 Economic Statement.
Further information can be found in the press release of 26 July 2010 issued by the Prime Minister.
This measure was originally reported in the Pre-Election Economic and Fiscal Outlook 2010.
Juvenile Diabetes Research Foundation — contribution
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | - | - | - | - |
The Government provided $5.0 million in 2009‑10 to the Juvenile Diabetes Research Foundation for the establishment of the Australian Type-1 Diabetes Clinical Trials Network.
The establishment of the Australian Type-1 Diabetes Clinical Trials Network will support the translation of clinical research into new methods to prevent and treat diabetes.
The cost of this measure will be met from within the existing resourcing of the Department of Health and Ageing.
This measure was originally reported in the Economic Statement 2010.
Life Saving Drugs Program — changes to listing for Fabrazyme®
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | - | - | - | - |
The Government will implement more cost-effective arrangements for the funding of agalsidase beta (Fabrazyme®) listed on the Life Saving Drugs Program (LSDP).
The savings from this measure were included as a 'decision taken but not yet announced' in the 2010‑11 Budget.
This measure was originally reported in the Pre-Election Economic and Fiscal Outlook 2010.
National Diabetes Services Scheme — extend access to insulin pump consumables
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | .. | .. | .. | .. |
The Government will provide $12,000 over four years to extend access to insulin pump consumables through the National Diabetes Services Scheme (NDSS), from 16 July 2010, for people with 'other' diabetes where insulin pump therapy is the last line of treatment. 'Other' diabetes is defined as diabetes caused by a genetic defect, pancreatic diseases, hormonal abnormalities, or exposure to certain drugs or chemicals.
Under the current NDSS guidelines, people with 'other' diabetes are not eligible to access Government-subsidised insulin pump consumables through the NDSS.
The NDSS aims to ensure that people with diabetes have timely, reliable and affordable access to products and services that help them effectively self-manage their condition.
This measure was originally reported in the Economic Statement 2010.
National Health and Hospitals Network — lead clinicians groups
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | - | - | - | - |
The Government will provide $58.1 million over four years to implement Lead Clinicians Groups at a local and national level. Lead Clinicians Groups will be utilised to improve clinical engagement across the health system. This includes drawing upon existing clinical engagement mechanisms in the States and Territories, where appropriate.
The initiative recognises the role of clinical leadership and expertise in delivering safer and higher quality care, to the benefit of patients and their families.
National Lead Clinicians Groups will help to develop and encourage the use of an evidence base for an appropriate quality health care system. Local Lead Clinicians Groups will provide clinical advice on optimal models of care and methods to improve clinical outcomes, and will work to achieve integrated local health services.
This measure was originally reported in the Economic Statement 2010.
Pharmaceutical Benefits Scheme — minor new listings
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | 7.0 | 11.6 | 15.0 | 18.0 |
| Medicare Australia | - | .. | 0.1 | 0.1 | 0.1 |
| Total | - | 7.0 | 11.7 | 15.0 | 18.0 |
The Government has agreed to a number of minor new listings on the Pharmaceutical
Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme since the 2010‑11 Budget, at a cost of $51.7 million over four years. This includes funding for administering payments through Medicare Australia.
Minor new listings include:
- Byetta®, for the treatment of Type 2 diabetes;
- Isentress®, for the treatment of Human Immunodeficiency Virus infection;
- Orgalutran®, for use in conjunction with in-vitro fertilisation treatment; and
- Remicade®, for the treatment of fistulising Crohn disease.
Further information can be found in the updates to the Schedule of Pharmaceutical Benefits issued by the Department of Health and Ageing.
This measure was originally reported in the Pre-Election Economic and Fiscal Outlook 2010.
Surfing Australia — high performance training facility — contribution
| 2009‑10 | 2010‑11 | 2011‑12 | 2012‑13 | 2013‑14 | |
|---|---|---|---|---|---|
| Department of Health and Ageing | - | - | - | - | - |
The Government will provide $2.0 million in 2010‑11 to Surfing Australia to assist with the construction of a national high performance surf training centre at Casuarina Beach in New South Wales.
The centre will include a dormitory, conference rooms, office and storage facilities, and will enable Surfing Australia to provide accreditation courses and camps for entry level surfers, coaches, surf school instructors, and elite surfers.
It is estimated that over 3,000 athletes will make use of the centre each year. The centre will maximise opportunities by linking with tertiary institutions including the Southern Cross University, New South Wales; and Griffith University, Queensland.
Funding for this measure was included as a 'decision taken but not yet announced' in the 2010‑11 Budget.
This measure was originally reported in the Pre-Election Economic and Fiscal Outlook 2010.
If www.budget.gov.au responds slowly or you are having trouble downloading a document, try one of the Budget Website Mirrors
Note: Where possible, Budget documents are available in HTML and for downloading in Portable Document Format(PDF). If you require further information on any of the tables or charts on this website, please contact The Treasury.
